271 related articles for article (PubMed ID: 29885994)
21. Effect of bevacizumab on radiation necrosis of the brain.
Gonzalez J; Kumar AJ; Conrad CA; Levin VA
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):323-6. PubMed ID: 17236958
[TBL] [Abstract][Full Text] [Related]
22. Reversal of cerebral radiation necrosis with bevacizumab treatment in 17 Chinese patients.
Wang Y; Pan L; Sheng X; Mao Y; Yao Y; Wang E; Zhang N; Dai J
Eur J Med Res; 2012 Aug; 17(1):25. PubMed ID: 22913802
[TBL] [Abstract][Full Text] [Related]
23. Targeted intraarterial anti-VEGF therapy for medically refractory radiation necrosis in the brain.
Dashti SR; Spalding A; Kadner RJ; Yao T; Kumar A; Sun DA; LaRocca R
J Neurosurg Pediatr; 2015 Jan; 15(1):20-5. PubMed ID: 25360851
[TBL] [Abstract][Full Text] [Related]
24. Bevacizumab treatment leads to observable morphological and metabolic changes in brain radiation necrosis.
Yonezawa S; Miwa K; Shinoda J; Nomura Y; Asano Y; Nakayama N; Ohe N; Yano H; Iwama T
J Neurooncol; 2014 Aug; 119(1):101-9. PubMed ID: 24789256
[TBL] [Abstract][Full Text] [Related]
25. Bevacizumab for Cerebral Radionecrosis: A Single-Center Experience.
Climans SA; Ramos RC; Jablonska PA; Shultz DB; Mason WP
Can J Neurol Sci; 2023 Jul; 50(4):573-578. PubMed ID: 35634744
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of chemoradiotherapy combined with bevacizumab in patients with nasopharyngeal carcinoma: A comparative study.
Zhang F; Yuan T; Gao M
J BUON; 2019; 24(3):1252-1258. PubMed ID: 31424687
[TBL] [Abstract][Full Text] [Related]
27. Comparative analysis of bevacizumab and LITT for treating radiation necrosis in previously radiated CNS neoplasms: a systematic review and meta-analysis.
Gecici NN; Gurses ME; Kaye B; Jimenez NLF; Berke C; Gökalp E; Lu VM; Ivan ME; Komotar RJ; Shah AH
J Neurooncol; 2024 May; 168(1):1-11. PubMed ID: 38619777
[TBL] [Abstract][Full Text] [Related]
28. Bevacizumab as a treatment option for radiation necrosis after cranial radiation therapy: a retrospective monocentric analysis.
Bodensohn R; Hadi I; Fleischmann DF; Corradini S; Thon N; Rauch J; Belka C; Niyazi M
Strahlenther Onkol; 2020 Jan; 196(1):70-76. PubMed ID: 31586230
[TBL] [Abstract][Full Text] [Related]
29. Prospective, Multicenter, Phase 2 Trial of Induction Chemotherapy Followed by Bio-Chemoradiotherapy for Locally Advanced Recurrent Nasopharyngeal Carcinoma.
Ng WT; Ngan RKC; Kwong DLW; Tung SY; Yuen KT; Kam MKM; Sze HCK; Yiu HHY; Chan LLK; Lung ML; Lee AWM
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):630-638. PubMed ID: 29413277
[TBL] [Abstract][Full Text] [Related]
30. Resolution of radiation necrosis with bevacizumab following radiation therapy for primary CNS lymphoma.
Vaios EJ; Batich KA; Buckley AF; Dunn-Pirio A; Patel MP; Kirkpatrick JP; Goudar R; Peters KB
Oncotarget; 2022; 13():576-582. PubMed ID: 35359747
[TBL] [Abstract][Full Text] [Related]
31. Bevacizumab for Radiation Induced Optic Neuritis Among Aggressive Residual/Recurrent Suprasellar Tumors: More Than a Mere Antineoplastic Effect.
Dutta P; Dhandapani S; Kumar N; Gupta P; Ahuja C; Mukherjee KK
World Neurosurg; 2017 Nov; 107():1044.e5-1044.e10. PubMed ID: 28754639
[TBL] [Abstract][Full Text] [Related]
32. Radiation Necrosis and White Matter Lesions in Pediatric Patients With Brain Tumors Treated With Pencil Beam Scanning Proton Therapy.
Bojaxhiu B; Ahlhelm F; Walser M; Placidi L; Kliebsch U; Mikroutsikos L; Morach P; Bolsi A; Lomax T; Pica A; Weber DC
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):987-996. PubMed ID: 29485079
[TBL] [Abstract][Full Text] [Related]
33. Diffusion Kurtosis as an in vivo Imaging Marker of Early Radiation-Induced Changes in Radiation-Induced Temporal Lobe Necrosis in Nasopharyngeal Carcinoma Patients.
Liyan L; Si W; Qian W; Yuhui S; Xiaoer W; Yuehua L; Wenbin L
Clin Neuroradiol; 2018 Sep; 28(3):413-420. PubMed ID: 28447147
[TBL] [Abstract][Full Text] [Related]
34. [Reduced radiation-induced brain necrosis in nasopharyngeal cancer patients with bevacizumab monotherapy].
Carl CO; Henze M
Strahlenther Onkol; 2019 Mar; 195(3):277-280. PubMed ID: 30689030
[No Abstract] [Full Text] [Related]
35. Bevacizumab for the Treatment of Radiation-Induced Cerebral Necrosis: A Systematic Review of the Literature.
Delishaj D; Ursino S; Pasqualetti F; Cristaudo A; Cosottini M; Fabrini MG; Paiar F
J Clin Med Res; 2017 Apr; 9(4):273-280. PubMed ID: 28270886
[TBL] [Abstract][Full Text] [Related]
36. A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastoma.
Weathers SP; Han X; Liu DD; Conrad CA; Gilbert MR; Loghin ME; O'Brien BJ; Penas-Prado M; Puduvalli VK; Tremont-Lukats I; Colen RR; Yung WKA; de Groot JF
J Neurooncol; 2016 Sep; 129(3):487-494. PubMed ID: 27406589
[TBL] [Abstract][Full Text] [Related]
37. Use of [(18)F]-FDG PET to predict response to neoadjuvant trastuzumab and docetaxel in patients with HER2-positive breast cancer, and addition of bevacizumab to neoadjuvant trastuzumab and docetaxel in [(18)F]-FDG PET-predicted non-responders (AVATAXHER): an open-label, randomised phase 2 trial.
Coudert B; Pierga JY; Mouret-Reynier MA; Kerrou K; Ferrero JM; Petit T; Kerbrat P; Dupré PF; Bachelot T; Gabelle P; Giard S; Coeffic D; Bougnoux P; Prevost JB; Paintaud G; Thibault G; Hernandez J; Coudert M; Arnould L; Berriolo-Riedinger A
Lancet Oncol; 2014 Dec; 15(13):1493-1502. PubMed ID: 25456368
[TBL] [Abstract][Full Text] [Related]
38. Modified XELIRI (capecitabine plus irinotecan) versus FOLFIRI (leucovorin, fluorouracil, and irinotecan), both either with or without bevacizumab, as second-line therapy for metastatic colorectal cancer (AXEPT): a multicentre, open-label, randomised, non-inferiority, phase 3 trial.
Xu RH; Muro K; Morita S; Iwasa S; Han SW; Wang W; Kotaka M; Nakamura M; Ahn JB; Deng YH; Kato T; Cho SH; Ba Y; Matsuoka H; Lee KW; Zhang T; Yamada Y; Sakamoto J; Park YS; Kim TW
Lancet Oncol; 2018 May; 19(5):660-671. PubMed ID: 29555258
[TBL] [Abstract][Full Text] [Related]
39. Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapy.
Finazzi T; Rordorf T; Ikenberg K; Huber GF; Guckenberger M; Garcia Schueler HI
BMC Cancer; 2018 Apr; 18(1):395. PubMed ID: 29625593
[TBL] [Abstract][Full Text] [Related]
40. Low-Dosage Bevacizumab Treatment: Effect on Radiation Necrosis After Gamma Knife Radiosurgery for Brain Metastases.
Weng Y; Shen J; Zhang L; Fang Z; Xiao F; Zhang C; Fan Z; Huang K; Wang L; Huang B; Wu F; Zhang T; Xu Q
Front Surg; 2021; 8():720506. PubMed ID: 34540887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
